<DOC>
	<DOCNO>NCT00263159</DOCNO>
	<brief_summary>The objective study evaluate therapeutic effectiveness cost-effectivity pharmaceutical care asthma patient .</brief_summary>
	<brief_title>Pharmaceutical Care Asthma Control Improvement ( PHARMACI ) -Study</brief_title>
	<detailed_description>The objective study evaluate therapeutic effectiveness cost-effectivity pharmaceutical care asthma patient . Patients randomly allocate control group ( = input pharmacist ) intervention group ( = pharmaceutical care baseline follow-up visit 6 month ) .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Patients persistent asthma Asthma treatment least 12 month Regular visitor participate community pharmacy Severe comorbidity &gt; 10 packyears smoke history Asthma Control Test score &lt; 15 =25</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>